Clinical Trial Update: Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating heart function during PD-1–inhibiting immunotherapy in melanoma and non-small cell cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Melanoma, Non-small Cell | Phase 4 | Status: UNKNOWN